Funding for this research was provided by:
Research fellow Startup Support from the Save Sight Institute and the School of Medical Sciences, The University of Sydney.
Cambridge Commonwealth, European and International Trust
John and Lucille van Geest Foundation.
Article History
Received: 4 September 2023
Revised: 13 February 2024
Accepted: 8 March 2024
First Online: 27 March 2024
Competing interests
: M.P.C. holds funding jointly provided by AstraZeneca for academic research and consults for Nura Bio, neither of which is directly relevant to this review. Neither of the remaining authors have interests to declare.